T1	Procedure 37 53	knee replacement
T2	Procedure 30 33;42 53	hip replacement
*	OR T1 T2
T3	Scope 30 53	hip or knee replacement
T4	Qualifier 20 29	bilateral
R1	Has_qualifier Arg1:T3 Arg2:T4	
T5	Procedure 76 81;89 105	total knee replacement
T6	Procedure 76 85;94 105	total hip replacement
*	OR T5 T6
T7	Competing_trial 57 179	atients undergoing total hip or knee replacement who have been enrolled in this study for a prior hip or knee replacement;
T8	Competing_trial 181 367	Patients who are concurrently enrolled in another active interventional clinical trial testing a drug or intervention known or believed to interact with aspirin, warfarin, or rivaroxaban
T9	Condition 390 406	contraindication
T10	Non-representable 370 461	Patients who have a contraindication to two or more of the three study prophylaxis regimens
T11	Pregnancy_considerations 464 617	Women who are pregnant or breastfeeding, as well as those of reproductive potential unless there is a negative urine pregnancy test on the day of surgery
T12	Drug 673 688	anticoagulation
T13	Negation 689 699	other than
T14	Drug 705 717	antiplatelet
R2	Has_negation Arg1:T14 Arg2:T13	
T15	Temporal 641 671	longer than the prior 6 months
R3	Has_temporal Arg1:T12 Arg2:T15	
T16	Condition 757 773;794 804	gastrointestinal hemorrhage
T17	Condition 775 783;794 804	cerebral hemorrhage
T18	Condition 794 804	hemorrhage
*	OR T18 T17 T16
T19	Temporal 805 837	within 3 months of the operation
T20	Reference_point 828 837	operation
R4	Has_index Arg1:T19 Arg2:T20	
T21	Scope 757 804	gastrointestinal, cerebral, or other hemorrhage
R5	Has_temporal Arg1:T21 Arg2:T19	
T22	Condition 885 895	hemostasis
T23	Qualifier 875 884	defective
R6	Has_qualifier Arg1:T22 Arg2:T23	
T24	Condition 925 933	bleeding
T25	Procedure 944 955	transfusion
T26	Procedure 960 969	treatment
T27	Scope 944 969	transfusion and treatment
R7	Has_scope Arg1:T24 Arg2:T27	
T28	Procedure 997 1016	operative procedure
T29	Qualifier 1031 1034	eye
T30	Qualifier 1036 1039	ear
T31	Qualifier 1044 1066	central nervous system
T32	Temporal 1067 1083	within one month
*	OR T29 T30 T31
T33	Scope 1031 1066	eye, ear, or central nervous system
R8	Has_scope Arg1:T28 Arg2:T33	
R9	Has_temporal Arg1:T28 Arg2:T32	
T34	Condition 1120 1132	hypertension
T35	Qualifier 1107 1119	uncontrolled
T36	Qualifier 1100 1106	severe
T37	Measurement 1138 1149	systolic BP
T38	Value 1150 1159	> 220mmHg
T39	Measurement 1163 1175	diastolic BP
T40	Value 1176 1185	> 120mmHg
R10	Has_value Arg1:T37 Arg2:T38	
R11	Has_value Arg1:T39 Arg2:T40	
*	OR T39 T37
T41	Scope 1138 1185	systolic BP > 220mmHg or diastolic BP > 120mmHg
R12	Has_qualifier Arg1:T34 Arg2:T35	
R13	Has_qualifier Arg1:T34 Arg2:T36	
R14	Has_scope Arg1:T34 Arg2:T41	
T42	Measurement 1214 1225	body weight
T44	Value 1229 1251	less than 41 kilograms
T45	Value 1253 1261	90.4 lbs
R16	Subsumes Arg1:T44 Arg2:T45	
R17	Has_value Arg1:T42 Arg2:T44	
T43	Person 1324 1333	prisoners
T46	Visit 1338 1355	institutionalized
*	OR T43 T46
